Update on drug importation, February 2026

Well-meaning advocates continue to propose importing medicine from foreign countries to lower drug prices for Americans. Past efforts didn’t pay off financially and raised public health risks. Here’s the state of this issue today.

[...]

Prescription drug freight fraud report, January 2026

The last two months of 2025 saw thousands of shipments of drugs popularized by social media imported into the U.S., as well as Xarelto and antibiotics. The shipments carried a wide range of product codes; some appropriate, and others far less so.

[...]

Pill press update: July 2025 through January 2026

thumbnail of first page of pill press report

Unregulated pill presses and molds make fake pills with dangerous and even deadly consequences for thousands of people every year. Read our July 2025 to January 2026 update about pill press seizures, policy developments, and legislation.

[...]

Employers, do you know how much you’re paying PBMs?

Employers, do you know how much you’re paying PBMs? Pharmacy benefit managers (PBM) tactics have increased costs for patients and healthcare purchasers all while driving community pharmacies out of business and failing to deliver on their promise to lower medication costs. Learn more about these tactics and what states are doing to address them.

[...]

Why not price caps?

Why are price caps a bad solution for medicine affordability? Americans need affordable access to medicines, but upper payment limits (UPLs) set by prescription drug affordability boards and Medicare Maximum Fair Prices (MFPs) are not viable solutions. In our complex drug supply chain, these price caps could bankrupt pharmacies and reduce patient access. Read our…

[...]

Intelligence Alert: Unlicensed med spas are selling unregulated diabetes and weight loss injectables that threaten public safety

front page of pdf about unsafe GLPs at medspas

Based on recent investigative reporting by the Partnership for Safe Medicines (PSM), patients in your state may be receiving weight loss injectables from unlicensed sources that do not meet FDA requirements for safety and sterility. PSM has established a dedicated contact from CBP/HSI to support investigations by state law enforcement on this issue.

[...]

Threats to HIV patients from criminals in the drug supply chain

Since 2019, federal prosecutors, drug manufacturers, and patient safety organizations have uncovered extensive criminal schemes targeting HIV medicines at every point in the supply chain. These schemes undermine trust in the healthcare system, and they endanger patients.

[...]